The efficacy of administering elbasvir/grazoprevir as hepatitis C therapy in hemodialysis patients with comorbid of hypertension and diabetes mellitus. Udayana In. Med. [Internet]. 2023 Dec. 1 [cited 2026 Apr. 19];7(2):35-8. Available from: https://jpdunud.org/index.php/JPD/article/view/228